Arrowhead Pharmaceuticals ARWR

$ 18.37 -1.82%

Quarterly report 2024-Q2
added 08-08-2024

Arrowhead Pharmaceuticals Deferred Revenue 2011-2024 | ARWR

Annual Deferred Revenue Arrowhead Pharmaceuticals

2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
866 K	74.1 M	111 M	19.3 M	77.8 M	600	5.27 M	2.57 M	103 K	103 K	103 K	37.5 K	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
111 M	600	24.3 M

Quarterly Deferred Revenue Arrowhead Pharmaceuticals

2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
-	-	-	866 K	16.9 M	29.8 M	66.3 M	74.1 M	-	97.9 M	109 M	111 M	151 M	111 M	6.74 M	19.3 M	19.3 M	19.3 M	54 M	77.8 M	77.8 M	77.8 M	125 M	600	943 K	1.56 M	1.88 M	5.27 M	5.27 M	5.27 M	25.6 M	2.57 M	2.57 M	2.57 M	109 K	103 K	103 K	103 K	109 K	103 K	103 K	103 K	109 K	103 K	103 K	103 K	109 K	37.5 K	37.5 K	37.5 K	101 K	-	-	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
151 M	600	27.6 M